These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Thioredoxin reductase--a new target for molecular medical investigations]. Zagrodzki P Postepy Hig Med Dosw; 2002; 56(2):155-67. PubMed ID: 12107960 [TBL] [Abstract][Full Text] [Related]
9. Thioredoxin and thioredoxin reductase as redox-sensitive molecular targets for cancer therapy. Pennington JD; Jacobs KM; Sun L; Bar-Sela G; Mishra M; Gius D Curr Pharm Des; 2007; 13(33):3368-77. PubMed ID: 18045191 [TBL] [Abstract][Full Text] [Related]
11. Roles of N-terminal active cysteines and C-terminal cysteine-selenocysteine in the catalytic mechanism of mammalian thioredoxin reductase. Fujiwara N; Fujii T; Fujii J; Taniguchi N J Biochem; 2001 May; 129(5):803-12. PubMed ID: 11328605 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of Thioredoxin/Thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione Homeostasis. Yan X; Zhang X; Wang L; Zhang R; Pu X; Wu S; Li L; Tong P; Wang J; Meng QH; Jensen VB; Girard L; Minna JD; Roth JA; Swisher SG; Heymach JV; Fang B Cancer Res; 2019 Jan; 79(1):125-132. PubMed ID: 30401714 [TBL] [Abstract][Full Text] [Related]
13. Activity assay of mammalian 2-cys peroxiredoxins using yeast thioredoxin reductase system. Kim JA; Park S; Kim K; Rhee SG; Kang SW Anal Biochem; 2005 Mar; 338(2):216-23. PubMed ID: 15745741 [TBL] [Abstract][Full Text] [Related]
14. Targeting thioredoxin reductase: anticancer agents and chemopreventive compounds. Zeng HH; Wang LH Med Chem; 2010 Sep; 6(5):286-97. PubMed ID: 20977412 [TBL] [Abstract][Full Text] [Related]
15. Thioredoxin Cross-Linking by Nitrogen Mustard in Lung Epithelial Cells: Formation of Multimeric Thioredoxin/Thioredoxin Reductase Complexes and Inhibition of Disulfide Reduction. Jan YH; Heck DE; Casillas RP; Laskin DL; Laskin JD Chem Res Toxicol; 2015 Nov; 28(11):2091-103. PubMed ID: 26451472 [TBL] [Abstract][Full Text] [Related]
16. Mutational studies confirm the catalytic triad in the human selenoenzyme thioredoxin reductase predicted by molecular modeling. Gromer S; Wessjohann LA; Eubel J; Brandt W Chembiochem; 2006 Nov; 7(11):1649-52. PubMed ID: 16977661 [No Abstract] [Full Text] [Related]
17. Molecular pharmacology and antitumor activity of palmarumycin-based inhibitors of thioredoxin reductase. Powis G; Wipf P; Lynch SM; Birmingham A; Kirkpatrick DL Mol Cancer Ther; 2006 Mar; 5(3):630-6. PubMed ID: 16546977 [TBL] [Abstract][Full Text] [Related]
18. Shikonin targets cytosolic thioredoxin reductase to induce ROS-mediated apoptosis in human promyelocytic leukemia HL-60 cells. Duan D; Zhang B; Yao J; Liu Y; Fang J Free Radic Biol Med; 2014 May; 70():182-93. PubMed ID: 24583460 [TBL] [Abstract][Full Text] [Related]
19. Protein disulfide-isomerase is a substrate for thioredoxin reductase and has thioredoxin-like activity. Lundström J; Holmgren A J Biol Chem; 1990 Jun; 265(16):9114-20. PubMed ID: 2188973 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium. Gallegos A; Berggren M; Gasdaska JR; Powis G Cancer Res; 1997 Nov; 57(21):4965-70. PubMed ID: 9354464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]